ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 45 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $68,000 | -86.6% | 140,660 | -89.3% | 0.00% | -91.4% |
| Q4 2018 | $508,000 | -47.8% | 1,312,366 | -0.1% | 0.04% | -27.1% |
| Q3 2018 | $974,000 | -53.9% | 1,313,431 | -60.2% | 0.05% | -69.8% |
| Q2 2018 | $2,111,000 | +22.7% | 3,298,193 | -56.4% | 0.16% | +2.6% |
| Q1 2018 | $1,721,000 | – | 7,568,191 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 339,796 | $163,000 | 0.04% |
| Malaga Cove Capital, LLC | 30,000 | $14,000 | 0.01% |
| Summit X, LLC | 35,000 | $16,000 | 0.01% |
| ARDSLEY ADVISORY PARTNERS LP | 75,000 | $36,000 | 0.01% |
| INTRUST BANK NA | 40,000 | $19,000 | 0.01% |
| Fosun International Ltd | 168,851 | $78,000 | 0.01% |
| Truvestments Capital LLC | 11,648 | $6,000 | 0.01% |
| DLD Asset Management, LP | 140,660 | $68,000 | 0.00% |
| Hartford Financial Management Inc. | 18,000 | $9,000 | 0.00% |
| SNS Financial Group, LLC | 26,000 | $12,000 | 0.00% |